Results 91 to 100 of about 3,591 (213)

Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN study

Therapeutic Advances in Respiratory Disease
Background: The extrafine single inhaler triple therapy (efSITT) containing beclomethasone dipropionate/formoterol fumarate/glycopyrronium 87/5/9 μg has proved to be efficacious in patients with chronic obstructive pulmonary disease (COPD) in randomized ...
Paschalis Steiropoulos, Niki Georgatou, George Krommidas, Konstantinos Bartziokas, Aliki Korkontzelou, Panos Katerelos, Petros Efstathopoulos, Dimosthenis Papapetrou, Stavros Theodorakis, Konstantinos Porpodis   +9 more
doaj   +1 more source

Prediction of disease progression, treatment response and dropout in chronic obstructive pulmonary disease (COPD). [PDF]

, 2014
Drug development in chronic obstructive pulmonary disease (COPD) has been characterised by unacceptably high failure rates. In addition to the poor sensitivity in forced expiratory volume in one second (FEV1), numerous causes are known to contribute to ...
Danhof, M, Della Pasqua, O, Facius, A, Maas, HJ, Musuamba, FT, Teutonico, D, Yang, S   +6 more
core   +1 more source

The European List of Key Medicines for Medical Education: A Modified Delphi Study

Clinical Pharmacology &Therapeutics, Volume 115, Issue 3, Page 515-524, March 2024.
Rational prescribing is essential for the quality of health care. However, many final‐year medical students and junior doctors lack prescribing competence to perform this task. The availability of a list of medicines that a junior doctor working in Europe should be able to independently prescribe safely and effectively without supervision could support
Erik M. Donker, Pietro Spitaleri Timpone, David J. Brinkman, Milan C. Richir, Paraskevi Papaioannidou, Robert Likic, Emilio J. Sanz, Thierry Christiaens, João N. Costa, Fabrizio De Ponti, Milo Gatti, Ylva Böttiger, Cornelis Kramers, Rahul Pandit, Michiel A. van Agtmael, Jelle Tichelaar, the Network of Teachers in Pharmacotherapy, Philippe Jorens, Galya Stavreva, Ivanka Kostadinova, Ivanka Atanasova, Maria Ganeva, Suzana Mimica, Greta Wozniak, Karel Urbánek, Ondřej Slanař, Anti Kalda, Eric Toussirot, Jean‐Luc Cracowski, Yves‐Marie Pers, Flora Capelle, Joachim Neumann, Rainer Böger, Ingolf Cascorbi, Ralf Regenthal, Markus Schwaninger, Silke Müller, Petra Thürmann, David Kerins, Helen Gallagher, James Curneen, Anne Harnett, Amelia Filippelli, Gianluca Trifirò, Santa Purvina, Baiba Jansone, Janet Mifsud, Ivan Kocić, Bogusław Okopień, Marlena Broncel, Dagmara Mirowska‐Guzel, José Alves, Simona Conea, Ioan Magyar, Olga Horvat, Mojca Krzan, Sebastjan Bevc, Francisco de Abajo, Magi Farre, M Isabel Lucena, Ylva Böttiger, Risto Huupponen, Michael Okorie, Martin Hawes, Vikas Kapil, Andrew Hitchings, Yoon Loke, Vesela Georgieva, Darko Simonov, Kameliya Sokolova, Zhivka Tsokeva, Tinde Halgato, Eduardo Puerta del Castillo, Tomi Kovacevic, Ovidiu Ourta, Candelaria Martín González, Madalin Alexandru Hasan, Lorena Paduraru, Masa Rapajic, Andjela Milak, Miroslav Ilić, Dimo Dimov, Peter Dieleman, Ellen Van Leeuwen, Mirko Petrovic, Chipurici Adrian Marius, Mihaela Zdrinca, Aleksandar Rašković, Nebojša Stilinović, Gavrail Poterov, Vanesa Pilicheva, Venka Tsankova, Evgenia Tsolova, Ilia Kostadinov, Delyan Delev, Darinka Dimitrova, Dimiter Terziivanov, Kristian Dominik Rudez, Vladimir Trkulja, Jelena Osmanovc Barilar, Jakša Vukojević, Martin Poruba, Radmila Vojkůvková, Hana Jureckova, Marek Pecha, Martin Mareš, Martin Šíma, Matthieu Bereau, Pierre‐Olivier Girodet, Theodora Angoulvant, François Montastruc, Matthieu Roustit, Radjiv Goulabchand, padern guillaume, Lucy Meunier, Patrick Karcher, Carole Greuez, Jonathan Tousch, Lucas Niglis, Aurélie Reiter, Marion Fourtage, Guillaume Becker, Jeanne Tardif d’Hamonville, Alexandra Audemard‐Verger, Adrien Lemaignen, Renke Maas, Jan‐Hendrik Lenz, Theresa Buuck, Kathrin Kohlen, Chrysanthi Sardeli, Eirini Apostolidou, Barry Corbett, Emanuel Raschi, Elisabetta Poluzzi, Federico Pea, Riccardo Ripamonti, Valeria Conti, Duilio Pagano, Riccardo Scoglio, Giuseppe Ando, Inese Sviestina, Zane Dzirkale, Andrew Aquilina, Maryanne Caruana, Maria Cordina, Christina Wlodek, Jeffrey Bonnici, Antoine Vella, Marianne Klemp, Ingrid Cameron, Piotr Jakubow, Iga Pawłowska, Łukasz Bułdak, Marcin Basiak, Aleksandra Bołdys, Mateusz Staciwa, Joana Caetano, Renata Ribeiro, Miran Brvar, Uroš Maver, Tina Maver, Eva Jakopin, Tadej Petreski, Juan‐Ignacio Pérez‐Calvo, Alejandro Venegas Robles, Ana Avedillo Salas, Miguel Puerro, Amelia García, Miguel Angel Maria‐Tablado, Daniel Fuster, Maria Luisa Bernal, Maria Jose Garcia Barrado, Susan Brooks, Anna Wakelin, Catrin Page, Jitka Rychlickova, Laura Peeters, Thomas Sierkstra, Michael Reumerman, Jarik de Geus, Eveline Van Poelgeest, Hiltsje Heemskerk, Reinier van Hest, Eline van Hattum, Floor van Rosse, Emma Kleipool, Rian Bibo, Geert Lefeber, Glenn Dumont, Narin Martens‐Akrawi, Yves Liem, Nella Leijten‐Wackwitz, Chiel Bakkum, Anne Dittrich, F.G.A. Versteegh, Michiel Warlé, Karen keijsers, Rob Rodrigues Pereira, Ben Semmekrot   +198 more
wiley   +1 more source

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma : results from two phase 3, randomised, double-blind, placebo-controlled trials [PDF]

, 2020
BACKGROUND: Reslizumab 3 mg/kg administered intravenously is approved for the treatment of severe eosinophilic asthma. We assessed the safety and efficacy of subcutaneous reslizumab 110 mg in two trials in patients with uncontrolled severe asthma and ...
Adir, Yochai, Bernstein, Jonathan A, Brusselle, Guy, Castro, Mario, Garin, Margaret, Hickey, Lisa, Humbert, Marc, Jacobs, Joshua, Marsteller, Douglas A, Maspero, Jorge Fernando, McElhattan, Jennifer, Murphy, Kevin, Vanlandingham, Rebecca, Virchow, J Christian   +13 more
core   +1 more source

A perspective current and past modes of inhalation therapy

Microbial Biotechnology, Volume 17, Issue 2, February 2024.
Abstract Inhalation is the preferred route of delivery for anti‐asthma and chronic obstructive pulmonary disease (COPD) drugs. The use of this route has demonstrated efficacy in these and other conditions, it offers rapid onset of action, and is associated with minimal systemic exposure, thereby reducing the risk of adverse effects.
José Canto Mangana, Kelsey Aguirre Schilder, José Ignacio Bretones‐Pedrinaci, Ana Rosa Márquez Blesa, Fermín Sánchez de Medina, Olga Martínez‐Augustin, Abdelali Daddaoua   +6 more
wiley   +1 more source

BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study

Journal of Asthma and Allergy, 2023
Fulvio Braido,1,2 Enrico Arnaboldi,1,2 Sara Barile,3 Luca Cavalieri,4 Eleonora Ingrassia,4 Maria Russo,1,2 Alessio Piraino4 1Respiratory Unit for Continuity of Care, IRCCS, Ospedale Policlinico San Martino, Genova, Italy; 2Department of Internal Medicine
Braido F, Arnaboldi E, Barile S, Cavalieri L, Ingrassia E, Russo M, Piraino A   +6 more
doaj  

Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids. [PDF]

, 2015
BACKGROUND: Asthma is the most common chronic medical condition among children and is one of the most common causes of hospitalisation and medical visits.
Aalbers, Adams, Adams, Ahmad, Anderson, Barnes, Berger, Bijl-Hofland, Brown, Brozek, Bumbacea, Bush, Cates, Cates, Cates, Cowie, Crane, Dorinsky, Dorinsky, Ducharme, Ducharme, Ernst, FitzGerald, FitzGerald, Fowler, Godard, Godard, Harrison, Hernández, Ind, Johnston, Koenig, Koenig, Lemanske, Lipworth, Liu, McMahon, Nathan, Nathan, Nelson, Nelson, Ni Chroinin, Obase, Oppenheimer, Paggiaro, Paggiaro, Papi, Pruteanu, Reddel, Rumbak, Salpeter, Self, Shamsul, Slankard, Spycher, Tattersfield, Wilding, Zangrilli, Zhang, Zhang   +59 more
core   +1 more source

Benefit:Risk Profile of Budesonide in Obstructive Airways Disease [PDF]

, 2019
Airway inflammation is a major contributing factor in both asthma and chronic obstructive pulmonary disease (COPD) and represents an important target for treatment.
Brattsand, Ralph, Lipworth, Brian, Tashkin, Donald P.   +2 more
core   +3 more sources

Inhaled corticosteroids for chronic obstructive pulmonary disease-the shifting treatment paradigm [PDF]

, 2015
Chronic obstructive pulmonary disease (COPD) guidelines suggest using inhaled corticosteroids (ICS) in patients with severe airflow limitation or those at high risk of exacerbations.
Duerden M, Miller DP, Morven Wilkie, Nannini LJ, Senderovitz T, Simon Finch, Stuart Schembri, Vestbo J, Yang IA   +8 more
core   +2 more sources

Penggunaan Extrafine Beclometason Diproprionat/Formoterol Fumarat pada PPOK [Combined Extrafine Beclomethason Diproprionat/Formoteral Fumarat in COPD]

Jurnal Respirasi, 2019
Chronic obstructive pulmonary disease (COPD) is a condition characterised by poorly reversible airflow limitation that is generally progressive and causes serious disability.
Sakinatus Syarifah, Muhammad Amin
doaj   +1 more source